-
1 Comment
Cosmo Bio Company,Limited is currently in a long term uptrend where the price is trading 0.2% above its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Cosmo Bio Company,Limited's total revenue rose by 13.6% to $2B since the same quarter in the previous year.
Its net income has increased by 550.0% to $99M since the same quarter in the previous year.
Based on the above factors, Cosmo Bio Company,Limited gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Diagnostics & Research |
| Exchange | TSE |
| CurrencyCode | JPY |
| ISIN | JP3298700000 |
| Market Cap | 8B |
|---|---|
| PE Ratio | 31.01 |
| Target Price | None |
| Dividend Yield | 3.3% |
| Beta | 0.11 |
Cosmo Bio Company,Limited, together with its subsidiaries, engages in the purchase and sale of research reagents, equipment, and contract services related to life science worldwide. The company distributes antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, and bacteria, as well as detection reagents, cell and tissue culture systems, and gene analysis systems; and research instruments, including electrophoresis apparatuses, cell culture labware, gene manipulation systems, and data analysis software.It also provides drug discovery and custom research services; clinical diagnostics; consigned services, such as intestinal flora analysis, tear fluid analysis, and cell assays services; and custom peptide synthesis and antibody production services. In addition, the company manufactures and sells cell/cell culture products comprising adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem cells, feeder cells, tumor cell lines, macrophage-related, and coating reagents; measurement and staining kits, detection/purification kits related to neurodementia, macrophage/immune, exosome, and anti-saccharification/anti-aging; and biotechnology research equipment, such as constant-temperature transport containers, aluminum block mat heat insulation devices, and dew condensation prevention glass plate. It serves universities, public research institutes, and companies engaged in biological science. Cosmo Bio Company, Limited was founded in 1978 and is headquartered in Koto, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3386.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026